Roles of advanced glycation end-products in the progression of diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 76-80

  Makino, Hirofumi ^a   Shikata, Kenichi ^b   Kushiro, Masahiko ^b   Hironaka, Kazue ^b   Yamasaki, Yasushi ^b   Sugimoto, Hikaru ^b   Ota, Zensuke ^b   Araki, Norie ^b   Horiuchi, Seikoh ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Advanced glycation end products; Diabetic nephropathy; Glomerulosclerosis; Glycation; Mesangium

Indexed keywords

COLLAGEN TYPE 5; COLLAGEN TYPE 6; MATRIX PROTEIN; SCHIFF BASE;

CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; GLYCATION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MESANGIUM; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STAINING; ULTRASTRUCTURE;

EID: 0030483826     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.76     Document Type: Conference Paper

References (41)

1. Jones RH, Hayakawa H, Mackay JD, Parsons V, Watkins PJ. Progression of diabetic nephropathy. Lancet 1979; i: 1105-1106
2. Makino H, Yamasaki Y, Haramoto T et al. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 1993; 68: 45-55
3. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
4. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151
5. Maillard LC. Actions des acides amines sur les sucres: formation des melanoidines par voie methodique. CR Acad Sci 1912; 154: 66-68
6. Domniczak MH. The significance of the products of the Maillard (Browning) reaction in diabetes. Diabet Med 1991; 8: 505-516
7. Cohen MP, Urdanivia E, Surma M, Wu VY. Increased glycosylation of glomerular basement membrane collagen in diabetes. Biochem Biophys Res Commun 1980; 95: 765-769
8. Makita Z, Bucala R, Eayfield E et al Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet 1994; 343: 1519-1521
9. Nakamura Y, Horii Y, Nishino T et al. Immunohistochemcial localization of advanced giycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 1993; 143: 1649-1656
10. Miyata S, Monnier V. Immunphistochemical detection of advanced glycosylation end products in diabetic tissue using monoclonal antibody to pyrraline. J Clin Invest 1992; 89: 1102-1112
11. Mitsuhashi T, Nakayama H, Itoh T et al. Immunohistochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 1993; 42: 826-832
12. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 1991; 266: 7329-7332
13. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992; 267: 10211-10214
14. Makino H, Shikata K, Hironaka K et al. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 1995; 48: 517-526
15. Pappenheimer JR, Renkin EM, Borrero LM. Filtration, diffusion and molecular sieving through peripheral capillary membrane. A contribution to the pore theory of capillary permeability. Am J Physiol 1951; 167: 13-46
16. Shikata K, Makino H, Ichiyasu, Ota Z. Three-dimensional meshwork structure of glomerular basement membrane revealed by chemical treatment. J Electron Microsc 1990; 39: 182-185
17. Ota Z, Makino H, Miyoshi A et al Electron microscopic demonstration of meshwork structure in human and bovine glomerular basement membranes. Acta Med Okayama 1977; 31: 339-342
18. Kubosawa H, Kondo Y. Ultrastructural localization of the glomerular basement membrane as revealed by the deep-etch method. Cell Tissue Res 1983; 242: 33-39
19. Ota Z, Shilkata K, Ota K. Nephrotic tunnels in glomerular basement membrane as revealed by a new electron microscopic method. J Am Soc Nephrol 1994; 4: 1965-1973
20. Tanaka K, Matui I, Kuroda K, Mitsushima A. A new ultra high resolution scanning electron microscope (HUST-1). Biomed SEM 1985; 14: 23-25 (in Japanese)
21. Hironaka K, Makino H, Yamasaki Y, Ota Z. Renal basement membranes by ultrahigh resolution scanning electron microscopy. Kidney Int 1993; 43: 333-345
22. Yamasaki Y, Makino H, Hironaka K, Ota Z. Three-dimensional architecture of rat giomerular basement membrane by ultra-high resolution scanning electron microscopy. Acta Med Okayama 1990; 44: 333-335
23. Hironaka K, Makino H, Yamasaki Y, Ota Z. Pores in the glomerular basement membrane revealed by ultrahigh resolution scanning electron microscopy. Nephron 1993; 64: 647-649
24. Yamasaki Y, Makino H, Ota Z. Meshwork structure in bovine glomerular and tubular basement membrane by ultra-high-resolution scanning electron microscopy. Nephron 1994; 66: 189-199
25. Shirato I, Tomino Y, Koide H, Sakai T. Fine structure of the glomerular basement membrane of rat kidney visualized by high-resolution scanning electron microscopy. Cell Tissue Res 1991; 266: 1-10
26. Anderson SS, Tsilibary EC, Charonis AS. Nonenzymatic glycosyl̂ation-induced̂ modifications of intact bovine kidney tubular basement membrane. J Clin invest 1993; 92: 3045-3052
27. Makino H, Hironaka K, Shikata K et al. Mesangial matrices act as mesangial channels to the juxtaglomerular zone. Nephron 1994; 66: 181-188
28. Mundel P, Elger M, Sakai T, Kriz W. Microfibrils are a major component of the mesangial matrix in the rat kidney. Cell Tissue Res 1988; 254: 183-187
29. Kanwar YS. Biophysiology of glomerular filtration and proteinuria. Lab Invest 1984; 51: 7-21
30. Kootstra CJ, Arkema A, Hogendoorn PCW et al. A novel rat mesangial matrix protein, MMP-50/100, involved in mesangial glomerul̀opathies. Lab Invest 1995; 73: 72-80
31. Makino H, Shikata K, Wieslander J et al. Localization of fibril/microfibril and basement membrane collagen in diabetic Rlomerulosclerosis in type 2 diabetes. Diabet Med 1994; 11: 304-311
32. Falk RJ, Scheinmman JI, Mauer SM, Michael AF. Polyantigenic expression of basement membrane constituents of diabetic nephropathy. Diabetes 1983; 32 (Suppl 2): 34-39
33. Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991; 139: 889-899
34. Kanwar YS, Rosenzweig L, Linker A, Jakubowski M. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 1983; 80: 225-227
35. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 1992; 41: 1070-1080
36. Makino H, Ikeda S, Haramoto T, Ota Z. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 1992; 61: 415-421
37. Tarsio JF, Regfer LA, Furcht LT. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes 1988; 37: 532-539
38. Charonis AS, Reger LA, Dege JE et al. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 1990; 39: 807-814
39. Charonis AS, Tsilibary EC. Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 1992; 41 (Suppl 2): 49-51
40. Abrass CK, Peterson CV, Raugi G. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988; 37: 1695-1702
41. Birkedal-Hansen H, Moore WGI, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250